A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability ...

Methotrexate is one of the oldest and most cost-effective medicines available for rheumatoid arthritis (RA). Its also one of the most commonly used RA therapies. Heres what to know about this drug if ...

Please provide your email address to receive an email when new articles are posted on . Patients with RA treated with first-line upadacitinib over 5 years had greater reductions in disease activity vs ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

Subcutaneous tocilizumab, either as monotherapy or in combination with methotrexate, demonstrated greater efficacy than methotrexate alone and was well tolerated in patients with active rheumatoid ...

Subcutaneous tocilizumab, alone or with methotrexate, showed superior efficacy over methotrexate monotherapy in treating rheumatoid arthritis in Chinese patients. The trial demonstrated higher ACR20 ...

Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...

Vienna, Austria - Patients with rheumatoid arthritis (RA) who had inadequate response to a first course of methotrexate but have not had major toxicity may be good candidates for a second round of ...

Add Yahoo as a preferred source to see more of our stories on Google. Tammi L Shlotzhauer is a distinguished American medic and the author of ‘Living with Rheumatoid Arthritis’ - Barbara Patskin Tammi ...